首页 > 最新文献

Radiology最新文献

英文 中文
MRI Tumor Regression Response to Neoadjuvant Chemotherapy Alone without Radiation for Rectal Adenocarcinoma. MRI 肿瘤消退对新辅助化疗(不放疗)治疗直肠腺癌的反应
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-08-01 DOI: 10.1148/radiol.232908
Yu Shen, Xiaoling Gong, Yazhou He, Wenjian Meng, Hanjiang Zeng, Mingtian Wei, Meng Qiu, Ziqiang Wang

Background Neoadjuvant chemotherapy (NCT) is gaining acceptance for the management of locally advanced rectal cancer (LARC) in patients without negative prognostic factors. However, the value of MRI in evaluating tumor response after NCT remains unclear. Purpose To investigate the accuracy of MRI in assessing pathologic complete response in participants with LARC who underwent surgery after NCT without radiation. Materials and Methods A retrospective imaging substudy was conducted within two consecutive prospective clinical trials: the expanded phase II trial (from December 2017 to May 2021) and the COPEC trial (comparison of tumor response to two or four cycles of neoadjuvant chemotherapy alone, ongoing from August 2021). All included participants received four cycles of capecitabine combined with oxaliplatin (or CAPOX) before surgery. Three radiologists who were blinded to the clinicopathologic data independently evaluated the tumor response using five methods, namely, MR tumor regression grade (MR-TRG) alone, diffusion-weighted imaging (DWI) alone, DWI-modified MR-TRG (DWImodMR-TRG), MRI complete response, and radiologic neoadjuvant response score. With pathologic assessment serving as the reference standard, the positive and negative predictive values, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) were determined to evaluate the accuracy and performance of these models. The AUCs of the models were compared using the DeLong test. Results A total of 224 participants were included, comprising 119 from the expanded phase II trial (median age, 61 years [IQR, 53-67]; 89 male) and 105 from the COPEC trial (median age, 59 years [IQR, 53-67]; 65 male). MR-TRG, DWI, DWImodMR-TRG, MRI complete response, and the radiologic neoadjuvant response score were associated with pathologic complete response. DWImodMR-TRG achieved the highest AUC of 0.90 (95% CI: 0.85, 0.95), with a specificity of 89% (162 of 182) and a negative predictive value of 93% (162 of 174). Conclusion MRI-based models were accurate for determining pathologic complete response in participants with LARC following NCT. DWI improved the predictive performance of MRI-based assessment. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Santiago and Shur in this issue.

背景 新辅助化疗(NCT)在治疗无不良预后因素的局部晚期直肠癌(LARC)患者中正逐渐被接受。然而,核磁共振成像在评估新辅助化疗后肿瘤反应方面的价值仍不明确。目的 研究核磁共振成像在评估无放射治疗后接受手术的 LARC 患者的病理完全反应方面的准确性。材料和方法 在两项连续的前瞻性临床试验中开展了一项回顾性成像子研究:扩大的II期试验(从2017年12月至2021年5月)和COPEC试验(比较肿瘤对两个或四个周期的单独新辅助化疗的反应,从2021年8月开始进行)。所有纳入的参与者都在手术前接受了四个周期的卡培他滨联合奥沙利铂(或CAPOX)治疗。三位对临床病理数据设盲的放射科医生采用五种方法独立评估肿瘤反应,即单纯磁共振肿瘤回归分级(MR-TRG)、单纯弥散加权成像(DWI)、DWI修饰MR-TRG(DWImodMR-TRG)、磁共振完全反应和放射学新辅助反应评分。以病理评估为参考标准,确定了阳性和阴性预测值、灵敏度、特异性和接收器操作特征曲线下面积(AUC),以评估这些模型的准确性和性能。使用 DeLong 检验对模型的 AUC 进行比较。结果 共纳入 224 名参与者,其中 119 名来自扩大 II 期试验(中位年龄 61 岁 [IQR,53-67];89 名男性),105 名来自 COPEC 试验(中位年龄 59 岁 [IQR,53-67];65 名男性)。MR-TRG、DWI、DWImodMR-TRG、MRI完全反应和放射学新辅助反应评分与病理完全反应相关。DWImodMR-TRG的AUC最高,为0.90(95% CI:0.85,0.95),特异性为89%(182例中的162例),阴性预测值为93%(174例中的162例)。结论 基于磁共振成像的模型能准确判断 NCT 后 LARC 患者的病理完全反应。DWI 提高了基于 MRI 评估的预测性能。©RSNA,2024 这篇文章有补充材料。另请参阅本期 Santiago 和 Shur 的社论。
{"title":"MRI Tumor Regression Response to Neoadjuvant Chemotherapy Alone without Radiation for Rectal Adenocarcinoma.","authors":"Yu Shen, Xiaoling Gong, Yazhou He, Wenjian Meng, Hanjiang Zeng, Mingtian Wei, Meng Qiu, Ziqiang Wang","doi":"10.1148/radiol.232908","DOIUrl":"10.1148/radiol.232908","url":null,"abstract":"<p><p>Background Neoadjuvant chemotherapy (NCT) is gaining acceptance for the management of locally advanced rectal cancer (LARC) in patients without negative prognostic factors. However, the value of MRI in evaluating tumor response after NCT remains unclear. Purpose To investigate the accuracy of MRI in assessing pathologic complete response in participants with LARC who underwent surgery after NCT without radiation. Materials and Methods A retrospective imaging substudy was conducted within two consecutive prospective clinical trials: the expanded phase II trial (from December 2017 to May 2021) and the COPEC trial (comparison of tumor response to two or four cycles of neoadjuvant chemotherapy alone, ongoing from August 2021). All included participants received four cycles of capecitabine combined with oxaliplatin (or CAPOX) before surgery. Three radiologists who were blinded to the clinicopathologic data independently evaluated the tumor response using five methods, namely, MR tumor regression grade (MR-TRG) alone, diffusion-weighted imaging (DWI) alone, DWI-modified MR-TRG (DWImodMR-TRG), MRI complete response, and radiologic neoadjuvant response score. With pathologic assessment serving as the reference standard, the positive and negative predictive values, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) were determined to evaluate the accuracy and performance of these models. The AUCs of the models were compared using the DeLong test. Results A total of 224 participants were included, comprising 119 from the expanded phase II trial (median age, 61 years [IQR, 53-67]; 89 male) and 105 from the COPEC trial (median age, 59 years [IQR, 53-67]; 65 male). MR-TRG, DWI, DWImodMR-TRG, MRI complete response, and the radiologic neoadjuvant response score were associated with pathologic complete response. DWImodMR-TRG achieved the highest AUC of 0.90 (95% CI: 0.85, 0.95), with a specificity of 89% (162 of 182) and a negative predictive value of 93% (162 of 174). Conclusion MRI-based models were accurate for determining pathologic complete response in participants with LARC following NCT. DWI improved the predictive performance of MRI-based assessment. © RSNA, 2024 <i>Supplemental material is available for this article.</i> See also the editorial by Santiago and Shur in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142073677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using AI to Identify Unremarkable Chest Radiographs for Automatic Reporting. 利用人工智能识别无异常胸片,以便自动报告。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-08-01 DOI: 10.1148/radiol.240272
Louis Lind Plesner, Felix C Müller, Mathias W Brejnebøl, Christian Hedeager Krag, Lene C Laustrup, Finn Rasmussen, Olav Wendelboe Nielsen, Mikael Boesen, Michael B Andersen

Background Radiology practices have a high volume of unremarkable chest radiographs and artificial intelligence (AI) could possibly improve workflow by providing an automatic report. Purpose To estimate the proportion of unremarkable chest radiographs, where AI can correctly exclude pathology (ie, specificity) without increasing diagnostic errors. Materials and Methods In this retrospective study, consecutive chest radiographs in unique adult patients (≥18 years of age) were obtained January 1-12, 2020, at four Danish hospitals. Exclusion criteria included insufficient radiology reports or AI output error. Two thoracic radiologists, who were blinded to AI output, labeled chest radiographs as "remarkable" or "unremarkable" based on predefined unremarkable findings (reference standard). Radiology reports were classified similarly. A commercial AI tool was adapted to output a chest radiograph "remarkableness" probability, which was used to calculate specificity at different AI sensitivities. Chest radiographs with missed findings by AI and/or the radiology report were graded by one thoracic radiologist as critical, clinically significant, or clinically insignificant. Paired proportions were compared using the McNemar test. Results A total of 1961 patients were included (median age, 72 years [IQR, 58-81 years]; 993 female), with one chest radiograph per patient. The reference standard labeled 1231 of 1961 chest radiographs (62.8%) as remarkable and 730 of 1961 (37.2%) as unremarkable. At 99.9%, 99.0%, and 98.0% sensitivity, the AI had a specificity of 24.5% (179 of 730 radiographs [95% CI: 21, 28]), 47.1% (344 of 730 radiographs [95% CI: 43, 51]), and 52.7% (385 of 730 radiographs [95% CI: 49, 56]), respectively. With the AI fixed to have a similar sensitivity as radiology reports (87.2%), the missed findings of AI and reports had 2.2% (27 of 1231 radiographs) and 1.1% (14 of 1231 radiographs) classified as critical (P = .01), 4.1% (51 of 1231 radiographs) and 3.6% (44 of 1231 radiographs) classified as clinically significant (P = .46), and 6.5% (80 of 1231) and 8.1% (100 of 1231) classified as clinically insignificant (P = .11), respectively. At sensitivities greater than or equal to 95.4%, the AI tool exhibited less than or equal to 1.1% critical misses. Conclusion A commercial AI tool used off-label could correctly exclude pathology in 24.5%-52.7% of all unremarkable chest radiographs at greater than or equal to 98% sensitivity. The AI had equal or lower rates of critical misses than radiology reports at sensitivities greater than or equal to 95.4%. These results should be confirmed in a prospective study. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Yoon and Hwang in this issue.

背景 放射科有大量无异常胸片,而人工智能 (AI) 可以通过提供自动报告改善工作流程。目的 估计人工智能能正确排除病理(即特异性)而不增加诊断错误的无异常胸片的比例。材料和方法 在这项回顾性研究中,丹麦的四家医院于 2020 年 1 月 1 日至 12 日为特定的成年患者(年龄≥18 岁)连续拍摄了胸片。排除标准包括放射学报告不足或 AI 输出错误。两名胸部放射科医生对人工智能输出结果视而不见,他们根据预先定义的无异常发现(参考标准)将胸片标记为 "显著 "或 "无异常"。放射学报告也进行了类似的分类。我们对商业人工智能工具进行了调整,以输出胸片 "显著性 "概率,并根据不同的人工智能灵敏度计算特异性。人工智能和/或放射学报告漏检的胸片由一名胸部放射科医生分级为危重、有临床意义或无临床意义。使用 McNemar 检验比较配对比例。结果 共纳入 1961 名患者(中位年龄 72 岁 [IQR,58-81 岁];993 名女性),每名患者一张胸片。参考标准将 1961 张胸片中的 1231 张(62.8%)标记为有特征,将 1961 张胸片中的 730 张(37.2%)标记为无特征。在灵敏度为 99.9%、99.0% 和 98.0% 时,AI 的特异性分别为 24.5%(730 张照片中的 179 张[95% CI:21, 28])、47.1%(730 张照片中的 344 张[95% CI:43, 51])和 52.7%(730 张照片中的 385 张[95% CI:49, 56])。在 AI 的灵敏度与放射学报告(87.2%)相似的情况下,AI 和报告的漏检结果分别有 2.2%(1231 张 X 光片中的 27 张)和 1.1%(1231 张 X 光片中的 14 张)被归类为危重(P = .01)、4.1%(1231 张 X 光片中的 51 张)和 3.6%(1231 张 X 光片中的 44 张)被归类为有临床意义(P = .46),6.5%(1231 张 X 光片中的 80 张)和 8.1%(1231 张 X 光片中的 100 张)被归类为无临床意义(P = .11)。在灵敏度大于或等于 95.4% 的情况下,人工智能工具的临界漏检率小于或等于 1.1%。结论 非标示使用的商用 AI 工具可正确排除 24.5%-52.7% 的无异常胸片中的病变,灵敏度大于或等于 98%。在灵敏度大于或等于 95.4% 的情况下,人工智能的重大漏诊率与放射学报告相当或更低。这些结果应在前瞻性研究中得到证实。RSNA, 2024 这篇文章有补充材料。另请参阅本期 Yoon 和 Hwang 的社论。
{"title":"Using AI to Identify Unremarkable Chest Radiographs for Automatic Reporting.","authors":"Louis Lind Plesner, Felix C Müller, Mathias W Brejnebøl, Christian Hedeager Krag, Lene C Laustrup, Finn Rasmussen, Olav Wendelboe Nielsen, Mikael Boesen, Michael B Andersen","doi":"10.1148/radiol.240272","DOIUrl":"10.1148/radiol.240272","url":null,"abstract":"<p><p>Background Radiology practices have a high volume of unremarkable chest radiographs and artificial intelligence (AI) could possibly improve workflow by providing an automatic report. Purpose To estimate the proportion of unremarkable chest radiographs, where AI can correctly exclude pathology (ie, specificity) without increasing diagnostic errors. Materials and Methods In this retrospective study, consecutive chest radiographs in unique adult patients (≥18 years of age) were obtained January 1-12, 2020, at four Danish hospitals. Exclusion criteria included insufficient radiology reports or AI output error. Two thoracic radiologists, who were blinded to AI output, labeled chest radiographs as \"remarkable\" or \"unremarkable\" based on predefined unremarkable findings (reference standard). Radiology reports were classified similarly. A commercial AI tool was adapted to output a chest radiograph \"remarkableness\" probability, which was used to calculate specificity at different AI sensitivities. Chest radiographs with missed findings by AI and/or the radiology report were graded by one thoracic radiologist as critical, clinically significant, or clinically insignificant. Paired proportions were compared using the McNemar test. Results A total of 1961 patients were included (median age, 72 years [IQR, 58-81 years]; 993 female), with one chest radiograph per patient. The reference standard labeled 1231 of 1961 chest radiographs (62.8%) as remarkable and 730 of 1961 (37.2%) as unremarkable. At 99.9%, 99.0%, and 98.0% sensitivity, the AI had a specificity of 24.5% (179 of 730 radiographs [95% CI: 21, 28]), 47.1% (344 of 730 radiographs [95% CI: 43, 51]), and 52.7% (385 of 730 radiographs [95% CI: 49, 56]), respectively. With the AI fixed to have a similar sensitivity as radiology reports (87.2%), the missed findings of AI and reports had 2.2% (27 of 1231 radiographs) and 1.1% (14 of 1231 radiographs) classified as critical (<i>P</i> = .01), 4.1% (51 of 1231 radiographs) and 3.6% (44 of 1231 radiographs) classified as clinically significant (<i>P</i> = .46), and 6.5% (80 of 1231) and 8.1% (100 of 1231) classified as clinically insignificant (<i>P</i> = .11), respectively. At sensitivities greater than or equal to 95.4%, the AI tool exhibited less than or equal to 1.1% critical misses. Conclusion A commercial AI tool used off-label could correctly exclude pathology in 24.5%-52.7% of all unremarkable chest radiographs at greater than or equal to 98% sensitivity. The AI had equal or lower rates of critical misses than radiology reports at sensitivities greater than or equal to 95.4%. These results should be confirmed in a prospective study. © RSNA, 2024 <i>Supplemental material is available for this article.</i> See also the editorial by Yoon and Hwang in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Lexicon for First-Trimester US: Society of Radiologists in Ultrasound Consensus Conference Recommendations. 头胎超声词典》:超声波放射医师协会共识会议建议。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-08-01 DOI: 10.1148/radiol.240122
Shuchi K Rodgers, Mindy M Horrow, Peter M Doubilet, Mary C Frates, Anne Kennedy, Rochelle Andreotti, Kristyn Brandi, Laura Detti, Sarah K Horvath, Aya Kamaya, Atsuko Koyama, Penelope Chun Lema, Katherine E Maturen, Tara Morgan, Sarah G Običan, Kristen Olinger, Roya Sohaey, Suneeta Senapati, Lori M Strachowski

The Society of Radiologists in Ultrasound convened a multisociety panel to develop a first-trimester US lexicon based on scientific evidence, societal guidelines, and expert consensus that would be appropriate for imagers, clinicians, and patients. Through a modified Delphi process with consensus of at least 80%, agreement was reached for preferred terms, synonyms, and terms to avoid. An intrauterine pregnancy (IUP) is defined as a pregnancy implanted in a normal location within the uterus. In contrast, an ectopic pregnancy (EP) is any pregnancy implanted in an abnormal location, whether extrauterine or intrauterine, thus categorizing cesarean scar implantations as EPs. The term pregnancy of unknown location is used in the setting of a pregnant patient without evidence of a definite or probable IUP or EP at transvaginal US. Since cardiac development is a gradual process and cardiac chambers are not fully formed in the first trimester, the term cardiac activity is recommended in lieu of 'heart motion' or 'heartbeat.' The terms 'living' and 'viable' should also be avoided in the first trimester. 'Pregnancy failure' is replaced by early pregnancy loss (EPL). When paired with various modifiers, EPL is used to describe a pregnancy in the first trimester that may or will not progress, is in the process of expulsion, or has either incompletely or completely passed. © RSNA and Elsevier, 2024 Supplemental material is available for this article. This article is a simultaneous joint publication in Radiology and American Journal of Obstetrics & Gynecology. All rights reserved. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either version may be used in citing this article. See also the editorial by Scoutt and Norton in this issue.

超声放射医师学会召集了一个多学会小组,根据科学证据、社会指南和专家共识制定适合成像人员、临床医师和患者的第一胎 US 术语。通过修改后的德尔菲流程(共识率至少达到 80%),就首选术语、同义词和避免使用的术语达成了一致意见。宫内妊娠(IUP)是指植入子宫正常位置的妊娠。相比之下,异位妊娠(EP)是指任何植入异常位置的妊娠,无论是宫外还是宫内,因此剖宫产疤痕妊娠被归类为异位妊娠。位置不明妊娠一词用于经阴道超声检查无明确或可能的 IUP 或 EP 证据的妊娠患者。由于心脏发育是一个渐进的过程,心腔在妊娠头三个月尚未完全形成,因此建议使用 "心脏活动 "一词代替 "心脏运动 "或 "心跳"。妊娠头三个月也应避免使用 "存活 "和 "存活 "等词语。妊娠失败 "被 "早孕损失"(EPL)取代。当与各种修饰词搭配使用时,EPL 用于描述妊娠前三个月可能或不会进展、正在排出、不完全或完全流产的妊娠。©RSNA和爱思唯尔,2024 本文章有补充材料。本文同时在《放射学》和《美国妇产科杂志》上联合发表。保留所有权利。除文体和拼写略有不同外,两篇文章完全相同,符合各自期刊的风格。在引用本文时,可使用其中任何一个版本。另请参阅 Scoutt 和 Norton 在本期发表的社论。
{"title":"A Lexicon for First-Trimester US: Society of Radiologists in Ultrasound Consensus Conference Recommendations.","authors":"Shuchi K Rodgers, Mindy M Horrow, Peter M Doubilet, Mary C Frates, Anne Kennedy, Rochelle Andreotti, Kristyn Brandi, Laura Detti, Sarah K Horvath, Aya Kamaya, Atsuko Koyama, Penelope Chun Lema, Katherine E Maturen, Tara Morgan, Sarah G Običan, Kristen Olinger, Roya Sohaey, Suneeta Senapati, Lori M Strachowski","doi":"10.1148/radiol.240122","DOIUrl":"10.1148/radiol.240122","url":null,"abstract":"<p><p>The Society of Radiologists in Ultrasound convened a multisociety panel to develop a first-trimester US lexicon based on scientific evidence, societal guidelines, and expert consensus that would be appropriate for imagers, clinicians, and patients. Through a modified Delphi process with consensus of at least 80%, agreement was reached for preferred terms, synonyms, and terms to avoid. An <i>intrauterine pregnancy</i> (IUP) is defined as a pregnancy implanted in a normal location within the uterus. In contrast, an <i>ectopic pregnancy</i> (EP) is any pregnancy implanted in an abnormal location, whether extrauterine or intrauterine, thus categorizing cesarean scar implantations as EPs. The term <i>pregnancy of unknown location</i> is used in the setting of a pregnant patient without evidence of a <i>definite</i> or <i>probable</i> IUP or EP at transvaginal US. Since cardiac development is a gradual process and cardiac chambers are not fully formed in the first trimester, the term <i>cardiac activity</i> is recommended in lieu of 'heart motion' or 'heartbeat.' The terms 'living' and 'viable' should also be avoided in the first trimester. 'Pregnancy failure' is replaced by <i>early pregnancy loss</i> (EPL). When paired with various modifiers, <i>EPL</i> is used to describe a pregnancy in the first trimester that may or will not progress, is in the process of expulsion, or has either incompletely or completely passed. © RSNA and Elsevier, 2024 <i>Supplemental material is available for this article.</i> This article is a simultaneous joint publication in <i>Radiology</i> and <i>American Journal of Obstetrics & Gynecology</i>. All rights reserved. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either version may be used in citing this article. See also the editorial by Scoutt and Norton in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142073667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease. CT 肠造影术描述纤维软化性克罗恩病的可靠性。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-08-01 DOI: 10.1148/radiol.233038
Florian Rieder, Christopher Ma, Jurij Hanzel, Joel G Fletcher, Mark E Baker, Zhongya Wang, Leonardo Guizzetti, Lisa M Shackelton, Julie Rémillard, Mihir Patel, Jiafei Niu, Ronald Ottichilo, Cynthia S Santillan, Nunzia Capozzi, Stuart A Taylor, David H Bruining, Guangyong Zou, Brian G Feagan, Vipul Jairath, Jordi Rimola

Background Standardized methods to measure and describe Crohn disease strictures at CT enterography are needed to guide clinical decision making and for use in therapeutic studies. Purpose To assess the reliability of CT enterography features to describe Crohn disease strictures and their correlation with stricture severity. Materials and Methods A retrospective study was conducted in 43 adult patients with symptomatic terminal ileal Crohn disease strictures who underwent standard-of-care CT enterography at a tertiary care center at the Cleveland Clinic between January 2008 and August 2016. After training on standardized definitions, four abdominal radiologists blinded to all patient information assessed imaging features (seven continuous measurements and nine observations) of the most distal ileal stricture in two separate sessions (separated by ≥2 weeks) in random order. Features with an interrater intraclass correlation coefficient (ICC) of 0.41 or greater (ie, moderate reliability or better) were considered reliable. Univariable and multivariable linear regression analysis identified reliable features associated with a visual analog scale of overall stricture severity. Significant reliable features were assessed as components of a CT enterography-based model to quantitate stricture severity. Results Examinations in 43 patients (mean age, 52 years ± 16 [SD]; 23 female) were evaluated. Five continuous measurements and six observations demonstrated at least moderate interrater reliability (interrater ICC range, 0.42 [95% CI: 0.25, 0.57] to 0.80 [95% CI: 0.67, 0.88]). Of these, 10 were univariably associated with stricture severity, and three continuous measurements-stricture length (interrater ICC, 0.64 [95% CI: 0.42, 0.81]), maximal associated small bowel dilation (interrater ICC, 0.80 [95% CI: 0.67, 0.88]), and maximal stricture wall thickness (interrater ICC, 0.50 [95% CI: 0.34, 0.62])-were independently associated (P value range, <.001 to .003) with stricture severity in a multivariable model. These three measurements were used to derive a well-calibrated (optimism-adjusted calibration slope = 1.00) quantitative model of stricture severity. Conclusion Standardized CT enterography measurements and observations can reliably describe terminal ileal Crohn disease strictures. Stricture length, maximal associated small bowel dilation, and maximal stricture wall thickness are correlated with stricture severity. © RSNA, 2024 Supplemental material is available for this article. See also the article by Rieder et al in this issue. See also the editorial by Galgano and Summerlin in this issue.

背景 需要标准化的方法来测量和描述 CT 肠造影中的克罗恩病狭窄,以指导临床决策和用于治疗研究。目的 评估 CT 肠造影特征描述克罗恩病狭窄的可靠性及其与狭窄严重程度的相关性。材料和方法 对 2008 年 1 月至 2016 年 8 月期间在克利夫兰诊所的三级医疗中心接受标准 CT 肠造影检查的 43 名有症状回肠末端克罗恩病狭窄的成人患者进行了回顾性研究。经过标准化定义的培训后,四名对患者信息完全保密的腹部放射科医生在两个独立的时段(间隔时间≥2周)以随机顺序评估了最远端的回肠狭窄的影像特征(七次连续测量和九次观察)。评分者间类内相关系数 (ICC) 达到或超过 0.41(即中等或更好的可靠性)的特征被认为是可靠的。单变量和多变量线性回归分析确定了与总体狭窄严重程度视觉模拟量表相关的可靠特征。重要的可靠特征被评估为基于 CT 肠造影模型的组成部分,以量化狭窄严重程度。结果 评估了 43 名患者(平均年龄 52 岁 ± 16 [SD];23 名女性)的检查结果。五项连续测量和六项观察结果显示了至少中等程度的检查者间可靠性(检查者间 ICC 范围为 0.42 [95% CI:0.25, 0.57] 至 0.80 [95% CI:0.67, 0.88])。其中,10 项与狭窄严重程度单变量相关,3 项连续测量--狭窄长度(评定者间 ICC,0.64 [95% CI:0.42, 0.81])、最大相关小肠扩张(评定者间 ICC,0.80 [95% CI:0.67, 0.88])和最大狭窄壁厚度(评定者间 ICC,0.50 [95% CI:0.34, 0.62])--独立相关(P 值范围,本文有补充材料。另请参阅本期 Rieder 等人的文章。另请参阅本期 Galgano 和 Summerlin 的社论。
{"title":"Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease.","authors":"Florian Rieder, Christopher Ma, Jurij Hanzel, Joel G Fletcher, Mark E Baker, Zhongya Wang, Leonardo Guizzetti, Lisa M Shackelton, Julie Rémillard, Mihir Patel, Jiafei Niu, Ronald Ottichilo, Cynthia S Santillan, Nunzia Capozzi, Stuart A Taylor, David H Bruining, Guangyong Zou, Brian G Feagan, Vipul Jairath, Jordi Rimola","doi":"10.1148/radiol.233038","DOIUrl":"10.1148/radiol.233038","url":null,"abstract":"<p><p>Background Standardized methods to measure and describe Crohn disease strictures at CT enterography are needed to guide clinical decision making and for use in therapeutic studies. Purpose To assess the reliability of CT enterography features to describe Crohn disease strictures and their correlation with stricture severity. Materials and Methods A retrospective study was conducted in 43 adult patients with symptomatic terminal ileal Crohn disease strictures who underwent standard-of-care CT enterography at a tertiary care center at the Cleveland Clinic between January 2008 and August 2016. After training on standardized definitions, four abdominal radiologists blinded to all patient information assessed imaging features (seven continuous measurements and nine observations) of the most distal ileal stricture in two separate sessions (separated by ≥2 weeks) in random order. Features with an interrater intraclass correlation coefficient (ICC) of 0.41 or greater (ie, moderate reliability or better) were considered reliable. Univariable and multivariable linear regression analysis identified reliable features associated with a visual analog scale of overall stricture severity. Significant reliable features were assessed as components of a CT enterography-based model to quantitate stricture severity. Results Examinations in 43 patients (mean age, 52 years ± 16 [SD]; 23 female) were evaluated. Five continuous measurements and six observations demonstrated at least moderate interrater reliability (interrater ICC range, 0.42 [95% CI: 0.25, 0.57] to 0.80 [95% CI: 0.67, 0.88]). Of these, 10 were univariably associated with stricture severity, and three continuous measurements-stricture length (interrater ICC, 0.64 [95% CI: 0.42, 0.81]), maximal associated small bowel dilation (interrater ICC, 0.80 [95% CI: 0.67, 0.88]), and maximal stricture wall thickness (interrater ICC, 0.50 [95% CI: 0.34, 0.62])-were independently associated (<i>P</i> value range, <.001 to .003) with stricture severity in a multivariable model. These three measurements were used to derive a well-calibrated (optimism-adjusted calibration slope = 1.00) quantitative model of stricture severity. Conclusion Standardized CT enterography measurements and observations can reliably describe terminal ileal Crohn disease strictures. Stricture length, maximal associated small bowel dilation, and maximal stricture wall thickness are correlated with stricture severity. © RSNA, 2024 <i>Supplemental material is available for this article.</i> See also the article by Rieder et al in this issue. See also the editorial by Galgano and Summerlin in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distribution of Solid Lung Nodules Presence and Size by Age and Sex in a Northern European Nonsmoking Population. 北欧非吸烟人群中按年龄和性别划分的实体肺结节存在和大小分布情况
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-08-01 DOI: 10.1148/radiol.231436
Jiali Cai, Marleen Vonder, Gert Jan Pelgrim, Mieneke Rook, Gerdien Kramer, Harry J M Groen, Geertruida H de Bock, Rozemarijn Vliegenthart

Background Most of the data regarding prevalence and size distribution of solid lung nodules originates from lung cancer screening studies that target high-risk populations or from Asian general cohorts. In recent years, the identification of lung nodules in non-high-risk populations, scanned for clinical indications, has increased. However, little is known about the presence of solid lung nodules in the Northern European nonsmoking population. Purpose To study the prevalence and size distribution of solid lung nodules by age and sex in a nonsmoking population. Materials and Methods Participants included nonsmokers (never or former smokers) from the population-based Imaging in Lifelines study conducted in the Northern Netherlands. Participants (age ≥ 45 years) with completed lung function tests underwent chest low-dose CT scans. Seven trained readers registered the presence and size of solid lung nodules measuring 30 mm3 or greater using semiautomated software. The prevalence and size of lung nodules (≥30 mm3), clinically relevant lung nodules (≥100 mm3), and actionable nodules (≥300 mm3) are presented by 5-year categories and by sex. Results A total of 10 431 participants (median age, 60.4 years [IQR, 53.8-70.8 years]; 56.6% [n = 5908] female participants; 46.1% [n = 4812] never smokers and 53.9% [n = 5619] former smokers) were included. Of these, 42.0% (n = 4377) had at least one lung nodule (male participants, 47.5% [2149 of 4523]; female participants, 37.7% [2228 of 5908]). The prevalence of lung nodules increased from age 45-49.9 years (male participants, 39.4% [219 of 556]; female participants, 27.7% [236 of 851]) to age 80 years or older (male participants, 60.7% [246 of 405]; female participants, 50.9% [163 of 320]). Clinically relevant lung nodules were present in 11.1% (1155 of 10 431) of participants, with prevalence increasing with age (male participants, 8.5%-24.4%; female participants, 3.7%-15.6%), whereas actionable nodules were present in 1.1%-6.4% of male participants and 0.6%-4.9% of female participants. Conclusion Lung nodules were present in a substantial proportion of all age groups in the Northern European nonsmoking population, with slightly higher prevalence for male participants than female participants. © RSNA, 2024 Supplemental material is available for this article.

背景有关肺实性结节的患病率和大小分布的数据大多来自针对高危人群或亚洲普通人群的肺癌筛查研究。近年来,在非高风险人群中,因临床适应症进行扫描而发现肺结节的情况有所增加。然而,人们对北欧非吸烟人群中是否存在肺实性结节知之甚少。目的 研究非吸烟人群中肺实性结节的患病率和大小分布(按年龄和性别划分)。材料和方法 参与者包括在荷兰北部进行的基于人群的生命线成像研究中的非吸烟者(从不吸烟或曾经吸烟)。完成肺功能测试的参与者(年龄≥ 45 岁)接受了胸部低剂量 CT 扫描。七名训练有素的阅片员使用半自动软件登记了 30 立方毫米或更大的实性肺结节的存在和大小。肺结节(≥30 立方毫米)、临床相关肺结节(≥100 立方毫米)和可采取行动的结节(≥300 立方毫米)的患病率和大小按 5 年类别和性别分列。结果 共纳入 10 431 名参与者(中位年龄 60.4 岁 [IQR,53.8-70.8 岁];56.6% [n = 5908] 女性参与者;46.1% [n = 4812] 从未吸烟者和 53.9% [n = 5619] 曾经吸烟者)。其中,42.0%(n = 4377)至少有一个肺结节(男性参与者,47.5% [4523 人中的 2149 人];女性参与者,37.7% [5908 人中的 2228 人])。从 45-49.9 岁(男性参与者,39.4% [556人中的219人];女性参与者,27.7% [851人中的236人])到 80 岁或以上(男性参与者,60.7% [405人中的246人];女性参与者,50.9% [320人中的163人]),肺结节的患病率不断增加。11.1%的参与者(10 431 人中有 1155 人)存在临床相关的肺部结节,随着年龄的增长,发病率也在增加(男性参与者为 8.5%-24.4%;女性参与者为 3.7%-15.6%),而 1.1%-6.4%的男性参与者和 0.6%-4.9%的女性参与者存在可采取行动的结节。结论 在北欧不吸烟人群中,各年龄组都有相当比例的人存在肺结节,男性参与者的发病率略高于女性参与者。© RSNA, 2024 可为本文提供补充材料。
{"title":"Distribution of Solid Lung Nodules Presence and Size by Age and Sex in a Northern European Nonsmoking Population.","authors":"Jiali Cai, Marleen Vonder, Gert Jan Pelgrim, Mieneke Rook, Gerdien Kramer, Harry J M Groen, Geertruida H de Bock, Rozemarijn Vliegenthart","doi":"10.1148/radiol.231436","DOIUrl":"10.1148/radiol.231436","url":null,"abstract":"<p><p>Background Most of the data regarding prevalence and size distribution of solid lung nodules originates from lung cancer screening studies that target high-risk populations or from Asian general cohorts. In recent years, the identification of lung nodules in non-high-risk populations, scanned for clinical indications, has increased. However, little is known about the presence of solid lung nodules in the Northern European nonsmoking population. Purpose To study the prevalence and size distribution of solid lung nodules by age and sex in a nonsmoking population. Materials and Methods Participants included nonsmokers (never or former smokers) from the population-based Imaging in Lifelines study conducted in the Northern Netherlands. Participants (age ≥ 45 years) with completed lung function tests underwent chest low-dose CT scans. Seven trained readers registered the presence and size of solid lung nodules measuring 30 mm<sup>3</sup> or greater using semiautomated software. The prevalence and size of lung nodules (≥30 mm<sup>3</sup>), clinically relevant lung nodules (≥100 mm<sup>3</sup>), and actionable nodules (≥300 mm<sup>3</sup>) are presented by 5-year categories and by sex. Results A total of 10 431 participants (median age, 60.4 years [IQR, 53.8-70.8 years]; 56.6% [<i>n</i> = 5908] female participants; 46.1% [<i>n</i> = 4812] never smokers and 53.9% [<i>n</i> = 5619] former smokers) were included. Of these, 42.0% (<i>n</i> = 4377) had at least one lung nodule (male participants, 47.5% [2149 of 4523]; female participants, 37.7% [2228 of 5908]). The prevalence of lung nodules increased from age 45-49.9 years (male participants, 39.4% [219 of 556]; female participants, 27.7% [236 of 851]) to age 80 years or older (male participants, 60.7% [246 of 405]; female participants, 50.9% [163 of 320]). Clinically relevant lung nodules were present in 11.1% (1155 of 10 431) of participants, with prevalence increasing with age (male participants, 8.5%-24.4%; female participants, 3.7%-15.6%), whereas actionable nodules were present in 1.1%-6.4% of male participants and 0.6%-4.9% of female participants. Conclusion Lung nodules were present in a substantial proportion of all age groups in the Northern European nonsmoking population, with slightly higher prevalence for male participants than female participants. © RSNA, 2024 <i>Supplemental material is available for this article.</i></p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141971773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum for: Gradualism: How Supplemental Breast Cancer Screening Will Become a Reality. 勘误:渐进主义:辅助乳腺癌筛查如何成为现实。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-08-01 DOI: 10.1148/radiol.249019
Thomas H Helbich, Panagiotis Kapetas
{"title":"Erratum for: Gradualism: How Supplemental Breast Cancer Screening Will Become a Reality.","authors":"Thomas H Helbich, Panagiotis Kapetas","doi":"10.1148/radiol.249019","DOIUrl":"10.1148/radiol.249019","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142073672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying Complete Responders Following Chemotherapy-only Neoadjuvant Treatment for Rectal Cancer: Role of MRI. 识别直肠癌化疗新辅助治疗后的完全反应者:核磁共振成像的作用。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-08-01 DOI: 10.1148/radiol.241724
Inês Santiago, Joshua D Shur
{"title":"Identifying Complete Responders Following Chemotherapy-only Neoadjuvant Treatment for Rectal Cancer: Role of MRI.","authors":"Inês Santiago, Joshua D Shur","doi":"10.1148/radiol.241724","DOIUrl":"10.1148/radiol.241724","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142073675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability in Reporting of CT and MR Enterography: An Important Step toward Standardization. CT 和 MR 肠造影报告的可靠性:实现标准化的重要一步。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-08-01 DOI: 10.1148/radiol.241407
Samuel J Galgano, David S Summerlin
{"title":"Reliability in Reporting of CT and MR Enterography: An Important Step toward Standardization.","authors":"Samuel J Galgano, David S Summerlin","doi":"10.1148/radiol.241407","DOIUrl":"10.1148/radiol.241407","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Marriage of Anatomy and Function in Coronary CT Angiography: An Ideal Combination is Almost Here. 冠状动脉 CT 血管造影中解剖与功能的结合:理想组合就在眼前
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-08-01 DOI: 10.1148/radiol.241630
Valentin Sinitsyn
{"title":"Marriage of Anatomy and Function in Coronary CT Angiography: An Ideal Combination is Almost Here.","authors":"Valentin Sinitsyn","doi":"10.1148/radiol.241630","DOIUrl":"10.1148/radiol.241630","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. 核磁共振肠造影描述纤维化克罗恩病特征的可靠性。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-08-01 DOI: 10.1148/radiol.233039
Florian Rieder, Mark E Baker, David H Bruining, Jeff L Fidler, Eric C Ehman, Shannon P Sheedy, Jay P Heiken, Justin M Ream, David R Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S Lee, Stuart A Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wang, Julie Rémillard, Rickey E Carter, Ronald Ottichilo, Norma Atkinson, Mohamed Tausif Siddiqui, Venkata C Sunkesula, Christopher Ma, Claire E Parker, Julian Panés, Jordi Rimola, Vipul Jairath, Brian G Feagan, Joel G Fletcher

Background Clinical decision making and drug development for fibrostenosing Crohn disease is constrained by a lack of imaging definitions, scoring conventions, and validated end points. Purpose To assess the reliability of MR enterography features to describe Crohn disease strictures and determine correlation with stricture severity. Materials and Methods A retrospective study of patients with symptomatic terminal ileal Crohn disease strictures who underwent MR enterography at tertiary care centers (Cleveland Clinic: September 2013 to November 2020; Mayo Clinic: February 2008 to March 2019) was conducted by using convenience sampling. In the development phase, blinded and trained radiologists independently evaluated 26 MR enterography features from baseline and follow-up examinations performed more than 6 months apart, with no bowel resection performed between examinations. Follow-up examinations closest to 12 months after baseline were selected. Reliability was assessed using the intraclass correlation coefficient (ICC). In the validation phase, after five features were redefined, reliability was re-estimated in an independent convenience sample using baseline examinations. Multivariable linear regression analysis identified features with at least moderate interrater reliability (ICC ≥0.41) that were independently associated with stricture severity. Results Ninety-nine (mean age, 40 years ± 14 [SD]; 50 male) patients were included in the development group and 51 (mean age, 45 years ± 16 [SD]; 35 female) patients were included in the validation group. In the development group, nine features had at least moderate interrater reliability. One additional feature demonstrated moderate reliability in the validation group. Stricture length (ICC = 0.85 [95% CI: 0.75, 0.91] and 0.91 [95% CI: 0.75, 0.96] in development and validation phase, respectively) and maximal associated small bowel dilation (ICC = 0.74 [95% CI: 0.63, 0.80] and 0.73 [95% CI: 0.58, 0.87] in development and validation group, respectively) had the highest interrater reliability. Stricture length, maximal stricture wall thickness, and maximal associated small bowel dilation were independently (regression coefficients, 0.09-3.97; P < .001) associated with stricture severity. Conclusion MR enterography definitions and scoring conventions for reliably assessing features of Crohn disease strictures were developed and validated, and feature correlation with stricture severity was determined. © RSNA, 2024 Supplemental material is available for this article. See also the article by Rieder and Ma et al in this issue. See also the editorial by Galgano and Summerlin in this issue.

背景 由于缺乏成像定义、评分惯例和有效终点,限制了纤维狭窄性克罗恩病的临床决策和药物开发。目的 评估 MR 肠造影特征描述克罗恩病狭窄的可靠性,并确定与狭窄严重程度的相关性。材料和方法 对在三级医疗中心(克利夫兰诊所:2013 年 9 月至 2020 年 11 月;梅西医院:2013 年 9 月至 2020 年 11 月)接受 MR 肠造影检查的无症状回肠末端克罗恩病狭窄患者进行回顾性研究:克利夫兰诊所:2013 年 9 月至 2020 年 11 月;梅奥诊所:2008 年 2 月至 2019 年 3 月:研究采用方便抽样法进行。在开发阶段,经过培训的盲人放射科医生独立评估了基线检查和相隔 6 个月以上的随访检查中的 26 项 MR 肠道造影特征,两次检查之间未进行肠切除术。选择的随访检查时间与基线检查时间相隔最接近 12 个月。可靠性采用类内相关系数(ICC)进行评估。在验证阶段,重新定义了五个特征后,使用基线检查在独立的方便样本中重新估计了可靠性。多变量线性回归分析确定了至少具有中度评分者间可靠性(ICC ≥0.41)的特征,这些特征与狭窄严重程度独立相关。结果 99名患者(平均年龄为40岁±14岁[SD];50名男性)被纳入开发组,51名患者(平均年龄为45岁±16岁[SD];35名女性)被纳入验证组。在开发组中,9 个特征至少具有中等程度的互测可靠性。在验证组中,还有一个特征具有中等程度的可靠性。在开发阶段和验证阶段,狭窄长度(ICC = 0.85 [95% CI:0.75, 0.91] 和 0.91 [95% CI:0.75, 0.96])和最大相关小肠扩张(ICC = 0.74 [95% CI:0.63, 0.80] 和 0.73 [95% CI:0.58, 0.87])的评分者间可靠性最高。狭窄长度、最大狭窄壁厚度和最大相关小肠扩张均与狭窄严重程度独立相关(回归系数为 0.09-3.97; P < .001)。结论 制定并验证了 MR 肠造影定义和评分规则,以可靠地评估克罗恩病狭窄的特征,并确定了特征与狭窄严重程度的相关性。©RSNA,2024 这篇文章有补充材料。另请参阅本期 Rieder 和 Ma 等人的文章。另请参阅本期 Galgano 和 Summerlin 的社论。
{"title":"Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease.","authors":"Florian Rieder, Mark E Baker, David H Bruining, Jeff L Fidler, Eric C Ehman, Shannon P Sheedy, Jay P Heiken, Justin M Ream, David R Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S Lee, Stuart A Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wang, Julie Rémillard, Rickey E Carter, Ronald Ottichilo, Norma Atkinson, Mohamed Tausif Siddiqui, Venkata C Sunkesula, Christopher Ma, Claire E Parker, Julian Panés, Jordi Rimola, Vipul Jairath, Brian G Feagan, Joel G Fletcher","doi":"10.1148/radiol.233039","DOIUrl":"10.1148/radiol.233039","url":null,"abstract":"<p><p>Background Clinical decision making and drug development for fibrostenosing Crohn disease is constrained by a lack of imaging definitions, scoring conventions, and validated end points. Purpose To assess the reliability of MR enterography features to describe Crohn disease strictures and determine correlation with stricture severity. Materials and Methods A retrospective study of patients with symptomatic terminal ileal Crohn disease strictures who underwent MR enterography at tertiary care centers (Cleveland Clinic: September 2013 to November 2020; Mayo Clinic: February 2008 to March 2019) was conducted by using convenience sampling. In the development phase, blinded and trained radiologists independently evaluated 26 MR enterography features from baseline and follow-up examinations performed more than 6 months apart, with no bowel resection performed between examinations. Follow-up examinations closest to 12 months after baseline were selected. Reliability was assessed using the intraclass correlation coefficient (ICC). In the validation phase, after five features were redefined, reliability was re-estimated in an independent convenience sample using baseline examinations. Multivariable linear regression analysis identified features with at least moderate interrater reliability (ICC ≥0.41) that were independently associated with stricture severity. Results Ninety-nine (mean age, 40 years ± 14 [SD]; 50 male) patients were included in the development group and 51 (mean age, 45 years ± 16 [SD]; 35 female) patients were included in the validation group. In the development group, nine features had at least moderate interrater reliability. One additional feature demonstrated moderate reliability in the validation group. Stricture length (ICC = 0.85 [95% CI: 0.75, 0.91] and 0.91 [95% CI: 0.75, 0.96] in development and validation phase, respectively) and maximal associated small bowel dilation (ICC = 0.74 [95% CI: 0.63, 0.80] and 0.73 [95% CI: 0.58, 0.87] in development and validation group, respectively) had the highest interrater reliability. Stricture length, maximal stricture wall thickness, and maximal associated small bowel dilation were independently (regression coefficients, 0.09-3.97; <i>P</i> < .001) associated with stricture severity. Conclusion MR enterography definitions and scoring conventions for reliably assessing features of Crohn disease strictures were developed and validated, and feature correlation with stricture severity was determined. © RSNA, 2024 <i>Supplemental material is available for this article.</i> See also the article by Rieder and Ma et al in this issue. See also the editorial by Galgano and Summerlin in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366673/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Radiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1